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First Transgenic Animal Developed
via Retroviral DNA Insertion into
Male Germ-Line Stem Cells
By Stephen Bradt

cientists at the School have successfully
used a retrovirus to modify genes in
spermatogonial stem cells in a mouse —
the first instance, in any species, of a transgenic
animal created by inserting a gene into male
germ-line stem cells.
The inserted gene subsequently appeared in
approximately 4.5 percent of offspring of mice
transplanted with the altered stem cells, and
was transmitted to at least three succeeding
generations.
The work was the cover story in the Nov. 6
issue of the Proceedings of the National Academy of Sciences. The findings should enable the
creation of transgenic individuals in a wide
range of species, permitting scientists to develop research models for study of numerous
human diseases.
Led by Ralph L. Brinster, Richard King
Mellon Professor of Reproductive Physiology
at the School, the scientists succeeded in inserting a foreign gene — in this case the common
reporter gene lacZ, whose product is the
enzyme fl-galactosidase — into 2 to 20 percent
of mouse spermatogonial stem cells in laboratory experiments, a tenfold improvement over
previous attempts.
“These results indicate that there is no
intrinsic barrier to the genetic engineering of
spermatogonial stem cells using retroviruses,
and that once inserted, the foreign genes will
continue to be transmitted and expressed from
one generation to the next,” said Dr. Brinster.
All male mammals harbor many spermatogonial stem cells, key repositories of genetic
material whose daughter cells give rise after
puberty to sperm. In the human male, approximately 1,000 sperm cells, each carrying a different combination of genetic material, are
generated in this manner with each heartbeat.
Whereas the female germ cell, the egg, stops
dividing before birth, male germ-line stem cells
continue to divide throughout life.
Of the various types of stem cells, only two
— spermatogonial and hematopoeitic stem
cells — can be positively identified using functional assays. This makes them valuable models
for other types of stem cells, such as those that
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give rise to skin, the lining of the intestines,
brain, muscle and liver.
Spermatogonial stem cells are of additional
interest for transgenics applications because
they are the only cells, including all other stem
cells, that undergo self-renewal throughout an
animal’s lifetime and contribute genes to subsequent generations. Previous attempts to
genetically alter this unique type of stem cell,
either through retroviruses or other methods,
have met with little success.
Brinster’s work is unusual in that his transgenic mice were created using cells from male
animals. Transgenic animals are generally produced by inserting foreign DNA into cells
derived from females, such as oocytes, eggs and
blastocysts. Brinster’s group has demonstrated
that the efficiency of generating transgenic mice
through spermatogonial stem cells is roughly
equivalent to that of female-derived cells.
“Questions had been raised regarding
whether male germ-line stem cells could be
transduced with a retroviral vector and
whether any gene introduced would be
silenced,” Brinster said. “Our work clearly
demonstrates that the stem cell can be transduced at relatively high efficiency and expression is not silenced. About 10 percent of stem
cells carry active genes that are transmitted for
at least three generations.”
Retroviruses are the most common vehicles
for introducing genes in human somatic cell
gene therapy, and some scientists had
expressed concern that this approach might
result in genetic alterations to germ-line cells.
Brinster’s paper indicates that the germ cells
are indeed susceptible to insertion of foreign
genes via retroviruses, although the somatic
cells that surround stem cells in the body most
likely provide a protective shield.
Brinster was joined in the work by Makoto
Nagano, now at McGill University, and Clayton
J. Brinster, Kyle E. Orwig, Buom-Yong Ryu and
Mary R. Avarbock, all of the Department of
Animal Biology at the School. Their work was
supported by the National Institutes of Health,
the Commonwealth and General Assembly of
Pennsylvania and the Robert J. Kleberg Jr. and
Helen C. Kleberg Foundation.
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